AP2005003264A0 - Novel imidazole compounds as transforming growth factor (TGD) inhibitors. - Google Patents
Novel imidazole compounds as transforming growth factor (TGD) inhibitors.Info
- Publication number
- AP2005003264A0 AP2005003264A0 AP2005003264A AP2005003264A AP2005003264A0 AP 2005003264 A0 AP2005003264 A0 AP 2005003264A0 AP 2005003264 A AP2005003264 A AP 2005003264A AP 2005003264 A AP2005003264 A AP 2005003264A AP 2005003264 A0 AP2005003264 A0 AP 2005003264A0
- Authority
- AP
- ARIPO
- Prior art keywords
- tgd
- inhibitors
- growth factor
- transforming growth
- imidazole compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41189402P | 2002-09-18 | 2002-09-18 | |
| US48452203P | 2003-07-02 | 2003-07-02 | |
| PCT/IB2003/003833 WO2004026859A1 (en) | 2002-09-18 | 2003-09-08 | Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2005003264A0 true AP2005003264A0 (en) | 2005-03-31 |
Family
ID=32033577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2005003264A AP2005003264A0 (en) | 2002-09-18 | 2003-09-08 | Novel imidazole compounds as transforming growth factor (TGD) inhibitors. |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US7153872B2 (xx) |
| EP (1) | EP1542990B1 (xx) |
| JP (1) | JP4547271B2 (xx) |
| KR (1) | KR20050057392A (xx) |
| CN (1) | CN1681805A (xx) |
| AP (1) | AP2005003264A0 (xx) |
| AR (1) | AR041274A1 (xx) |
| AT (1) | ATE433968T1 (xx) |
| AU (1) | AU2003263404A1 (xx) |
| BR (1) | BR0314372A (xx) |
| CA (1) | CA2498047C (xx) |
| CO (1) | CO5550453A2 (xx) |
| DE (1) | DE60328028D1 (xx) |
| EA (1) | EA200500378A1 (xx) |
| EC (1) | ECSP055680A (xx) |
| ES (1) | ES2325687T3 (xx) |
| HR (1) | HRP20050252A2 (xx) |
| IS (1) | IS7712A (xx) |
| MA (1) | MA27441A1 (xx) |
| MX (1) | MXPA05002981A (xx) |
| NO (1) | NO20051008L (xx) |
| OA (1) | OA12928A (xx) |
| PA (1) | PA8583301A1 (xx) |
| PE (1) | PE20050072A1 (xx) |
| PL (1) | PL375980A1 (xx) |
| TW (1) | TW200404793A (xx) |
| UY (1) | UY27982A1 (xx) |
| WO (1) | WO2004026859A1 (xx) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR039241A1 (es) * | 2002-04-04 | 2005-02-16 | Biogen Inc | Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos |
| UA80295C2 (en) * | 2002-09-06 | 2007-09-10 | Biogen Inc | Pyrazolopyridines and using the same |
| JP4519657B2 (ja) * | 2002-09-18 | 2010-08-04 | ファイザー・プロダクツ・インク | 形質転換成長因子（ｔｇｆ）阻害剤としての新規なピラゾ−ル化合物 |
| CN1681805A (zh) * | 2002-09-18 | 2005-10-12 | 辉瑞产品公司 | 作为转化生长因子(tgf)抑制剂的新的咪唑类化合物 |
| DE60327443D1 (de) | 2002-09-18 | 2009-06-10 | Pfizer Prod Inc | Neue oxazolverbindungen als inhibitoren des transforming growth factor (tgf) |
| PA8595001A1 (es) * | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
| KR100749566B1 (ko) | 2004-04-21 | 2007-08-16 | 이화여자대학교 산학협력단 | Ａｌｋ5 및/또는 ａｌｋ4 억제제로 유효한 2-피리딜이치환된 이미다졸 유도체 |
| US20080319012A1 (en) * | 2004-04-21 | 2008-12-25 | In2Gen Co., Ltd. | 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| KR101170925B1 (ko) | 2004-06-18 | 2012-08-07 | 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 | 암 치료용 키네신 방추 단백질 (ｋｓｐ) 억제제로서의ｎ-(1-(1-벤질-4-페닐-1ｈ-이미다졸-2-일)-2,2-디메틸프로필)벤자미드 유도체 및 관련 화합물 |
| JP2008511631A (ja) * | 2004-08-31 | 2008-04-17 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | ＴＧＦ−βインヒビターとしてのピリミジニルイミダゾール |
| EP1798229A4 (en) * | 2004-09-07 | 2009-07-29 | Sankyo Co | SUBSTITUTED BIPHENYL DERIVATIVE |
| PE20070427A1 (es) * | 2005-08-30 | 2007-04-21 | Novartis Ag | Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas |
| WO2007070866A2 (en) * | 2005-12-16 | 2007-06-21 | Alcon, Inc. | Control of intraocular pressure using alk5 modulation agents |
| CN1990473B (zh) * | 2005-12-30 | 2013-07-10 | 中国人民解放军军事医学科学院毒物药物研究所 | 三取代1h-咪唑类化合物、其制备方法、药物组合物及其制药用途 |
| EP2108017A2 (en) * | 2007-01-30 | 2009-10-14 | Biogen Idec MA, Inc. | Imidazolone compounds as tgf-beta family type i receptors, alk5 and/or alk4 antagonists |
| WO2008150827A1 (en) * | 2007-05-29 | 2008-12-11 | Smithkline Beecham Corporation | Naphthyridine, derivatives as p13 kinase inhibitors |
| WO2009047163A1 (en) * | 2007-10-10 | 2009-04-16 | F. Hoffmann-La Roche Ag | Methods of treating inflammatory diseases |
| EA201001456A1 (ru) * | 2008-03-21 | 2011-06-30 | Новартис Аг | Новые гетероциклические соединения и их применение |
| US8865732B2 (en) | 2008-03-21 | 2014-10-21 | Novartis Ag | Heterocyclic compounds and uses thereof |
| WO2009126861A2 (en) | 2008-04-11 | 2009-10-15 | Bristol-Myers Squibb Company | Triazolopyridine compounds useful as dgat1 inhibitors |
| WO2009126624A1 (en) | 2008-04-11 | 2009-10-15 | Bristol-Myers Squibb Company | Triazolo compounds useful as dgat1 inhibitors |
| WO2009155388A1 (en) | 2008-06-20 | 2009-12-23 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors |
| SG176105A1 (en) | 2009-06-26 | 2011-12-29 | Novartis Ag | 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17 |
| DE102009043260A1 (de) | 2009-09-28 | 2011-04-28 | Merck Patent Gmbh | Pyridinyl-imidazolonderivate |
| DE102009049679A1 (de) | 2009-10-19 | 2011-04-21 | Merck Patent Gmbh | Pyrazolopyrimidinderivate |
| US8080568B1 (en) | 2010-06-29 | 2011-12-20 | Ewha University - Industry Collaboration Foundation | 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors |
| USRE47141E1 (en) | 2010-06-29 | 2018-11-27 | EWHA University—Industry Collaboration Foundation | Methods of treating fibrosis, cancer and vascular injuries |
| DE102010049595A1 (de) | 2010-10-26 | 2012-04-26 | Merck Patent Gmbh | Chinazolinderivate |
| US9242969B2 (en) | 2013-03-14 | 2016-01-26 | Novartis Ag | Biaryl amide compounds as kinase inhibitors |
| ES2813875T3 (es) | 2014-01-01 | 2021-03-25 | Medivation Tech Llc | Compuestos y procedimientos de uso |
| UY36294A (es) | 2014-09-12 | 2016-04-29 | Novartis Ag | Compuestos y composiciones como inhibidores de quinasa |
| US10961239B2 (en) | 2017-01-05 | 2021-03-30 | Bristol-Myers Squibb Company | TGF beta receptor antagonists |
| EP3894401A2 (en) | 2018-12-11 | 2021-10-20 | Theravance Biopharma R&D IP, LLC | Naphthyridine and quinoline derivatives useful as alk5 inhibitors |
| IL293084A (en) * | 2019-11-22 | 2022-07-01 | Theravance Biopharma R& D Ip Llc | 5,1-Converted naphthyridines or quinolines as alk5 inhibitors |
| KR102539660B1 (ko) | 2020-08-20 | 2023-06-02 | 가천대학교 산학협력단 | 베타-폴리비닐리덴 플루오라이드 코팅층이 형성된 아연 음극 및 상기 음극을 포함하는 수계 아연 이온 전지 |
| KR20220031386A (ko) | 2020-09-04 | 2022-03-11 | 고려대학교 세종산학협력단 | 전기화학적 및 광전기화학적 수소 생산용 황화니켈 나노결정 촉매 및 이의 제조방법 |
| US20230089180A1 (en) * | 2021-08-13 | 2023-03-23 | Bisichem Co., Ltd. | Fused ring heteroaryl compounds and use thereof |
| CN115466260B (zh) * | 2022-09-06 | 2023-10-13 | 延边大学 | 含氨基酸结构的咪唑和噻唑类衍生物及其制备方法和应用 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3707475A (en) | 1970-11-16 | 1972-12-26 | Pfizer | Antiinflammatory imidazoles |
| IL83467A0 (en) * | 1986-08-15 | 1988-01-31 | Fujisawa Pharmaceutical Co | Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same |
| US5656644A (en) * | 1994-07-20 | 1997-08-12 | Smithkline Beecham Corporation | Pyridyl imidazoles |
| US6514977B1 (en) | 1997-05-22 | 2003-02-04 | G.D. Searle & Company | Substituted pyrazoles as p38 kinase inhibitors |
| AU7726898A (en) | 1997-05-22 | 1998-12-11 | G.D. Searle & Co. | Pyrazole derivatives as p38 kinase inhibitors |
| BR9809451A (pt) | 1997-05-22 | 2000-06-20 | Searle & Co | Pirazóis substituìdos com 3(5)-heteroarila como inibidores de quinase p38. |
| WO2000061576A1 (en) * | 1999-04-09 | 2000-10-19 | Smithkline Beecham Corporation | Triarylimidazoles |
| CO5271680A1 (es) * | 2000-02-21 | 2003-04-30 | Smithkline Beecham Corp | Compuestos |
| GB0007405D0 (en) * | 2000-03-27 | 2000-05-17 | Smithkline Beecham Corp | Compounds |
| PE20020506A1 (es) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
| WO2002040468A1 (en) | 2000-11-16 | 2002-05-23 | Smithkline Beecham Corporation | Compounds |
| GB0027987D0 (en) * | 2000-11-16 | 2001-01-03 | Smithkline Beecham Plc | Compounds |
| GB0100762D0 (en) | 2001-01-11 | 2001-02-21 | Smithkline Beecham Plc | Novel use |
| GB0102672D0 (en) | 2001-02-02 | 2001-03-21 | Glaxo Group Ltd | Compounds |
| US20040087623A1 (en) | 2001-02-02 | 2004-05-06 | Gellibert Francoise Jeanne | Pyrazole derivatives against tgf overexpression |
| JP2004521901A (ja) | 2001-02-02 | 2004-07-22 | グラクソ グループ リミテッド | Ｔｇｆ阻害剤としてのピラゾール |
| MXPA03008142A (es) * | 2001-03-09 | 2003-12-12 | Pfizer Prod Inc | Nuevos compuestos antiinflamatorios de bencimidazol. |
| AR039241A1 (es) * | 2002-04-04 | 2005-02-16 | Biogen Inc | Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos |
| JP2005539000A (ja) | 2002-07-31 | 2005-12-22 | スミスクライン・ビーチャム・コーポレイション | Ａｌｋ５阻害剤としての２−フェニルピリジン−４−イル誘導体 |
| EA200500286A1 (ru) | 2002-09-18 | 2005-08-25 | Пфайзер Продактс Инк. | Новые изотиазольные и изоксазольные соединения в качестве ингибиторов трансформирующего фактора роста (тфр) |
| JP4519657B2 (ja) | 2002-09-18 | 2010-08-04 | ファイザー・プロダクツ・インク | 形質転換成長因子（ｔｇｆ）阻害剤としての新規なピラゾ−ル化合物 |
| DE60327443D1 (de) | 2002-09-18 | 2009-06-10 | Pfizer Prod Inc | Neue oxazolverbindungen als inhibitoren des transforming growth factor (tgf) |
| AP2005003260A0 (en) | 2002-09-18 | 2005-03-31 | Pfizer Prod Inc | Novel triazole compounds as transforming growth factor (TGF) inhibitors. |
| CN1681805A (zh) | 2002-09-18 | 2005-10-12 | 辉瑞产品公司 | 作为转化生长因子(tgf)抑制剂的新的咪唑类化合物 |
| PA8595001A1 (es) | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
-
2003
- 2003-09-08 CN CNA038221608A patent/CN1681805A/zh active Pending
- 2003-09-08 CA CA002498047A patent/CA2498047C/en not_active Expired - Fee Related
- 2003-09-08 AU AU2003263404A patent/AU2003263404A1/en not_active Abandoned
- 2003-09-08 ES ES03797429T patent/ES2325687T3/es not_active Expired - Lifetime
- 2003-09-08 JP JP2004568901A patent/JP4547271B2/ja not_active Expired - Fee Related
- 2003-09-08 AP AP2005003264A patent/AP2005003264A0/xx unknown
- 2003-09-08 EP EP03797429A patent/EP1542990B1/en not_active Expired - Lifetime
- 2003-09-08 PL PL03375980A patent/PL375980A1/xx not_active Application Discontinuation
- 2003-09-08 BR BR0314372-4A patent/BR0314372A/pt not_active IP Right Cessation
- 2003-09-08 MX MXPA05002981A patent/MXPA05002981A/es active IP Right Grant
- 2003-09-08 WO PCT/IB2003/003833 patent/WO2004026859A1/en active Application Filing
- 2003-09-08 AT AT03797429T patent/ATE433968T1/de not_active IP Right Cessation
- 2003-09-08 EA EA200500378A patent/EA200500378A1/ru unknown
- 2003-09-08 OA OA1200500077A patent/OA12928A/en unknown
- 2003-09-08 KR KR1020057004570A patent/KR20050057392A/ko not_active Application Discontinuation
- 2003-09-08 DE DE60328028T patent/DE60328028D1/de not_active Expired - Lifetime
- 2003-09-16 UY UY27982A patent/UY27982A1/es not_active Application Discontinuation
- 2003-09-16 AR ARP030103358A patent/AR041274A1/es unknown
- 2003-09-16 PE PE2003000942A patent/PE20050072A1/es not_active Application Discontinuation
- 2003-09-17 TW TW092125609A patent/TW200404793A/zh unknown
- 2003-09-17 US US10/666,192 patent/US7153872B2/en not_active Expired - Fee Related
- 2003-09-17 PA PA20038583301A patent/PA8583301A1/es unknown
-
2005
- 2005-02-24 IS IS7712A patent/IS7712A/is unknown
- 2005-02-24 NO NO20051008A patent/NO20051008L/no unknown
- 2005-03-17 EC EC2005005680A patent/ECSP055680A/es unknown
- 2005-03-17 CO CO05024820A patent/CO5550453A2/es not_active Application Discontinuation
- 2005-03-17 HR HR20050252A patent/HRP20050252A2/hr not_active Application Discontinuation
- 2005-03-18 MA MA28155A patent/MA27441A1/fr unknown
-
2006
- 2006-11-10 US US11/558,624 patent/US7635702B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05002981A (es) | 2005-06-22 |
| TW200404793A (en) | 2004-04-01 |
| BR0314372A (pt) | 2005-07-19 |
| PA8583301A1 (es) | 2004-09-16 |
| ATE433968T1 (de) | 2009-07-15 |
| KR20050057392A (ko) | 2005-06-16 |
| HRP20050252A2 (en) | 2005-10-31 |
| MA27441A1 (fr) | 2005-07-01 |
| DE60328028D1 (de) | 2009-07-30 |
| ECSP055680A (es) | 2005-05-30 |
| ES2325687T3 (es) | 2009-09-14 |
| US20070088037A1 (en) | 2007-04-19 |
| AR041274A1 (es) | 2005-05-11 |
| EP1542990B1 (en) | 2009-06-17 |
| CA2498047A1 (en) | 2004-04-01 |
| PL375980A1 (en) | 2005-12-12 |
| CO5550453A2 (es) | 2005-08-31 |
| EA200500378A1 (ru) | 2005-08-25 |
| NO20051008L (no) | 2005-06-07 |
| EP1542990A1 (en) | 2005-06-22 |
| PE20050072A1 (es) | 2005-03-01 |
| US20040106608A1 (en) | 2004-06-03 |
| JP4547271B2 (ja) | 2010-09-22 |
| CN1681805A (zh) | 2005-10-12 |
| OA12928A (en) | 2006-10-13 |
| UY27982A1 (es) | 2004-04-30 |
| AU2003263404A1 (en) | 2004-04-08 |
| US7153872B2 (en) | 2006-12-26 |
| US7635702B2 (en) | 2009-12-22 |
| IS7712A (is) | 2005-02-24 |
| WO2004026859A1 (en) | 2004-04-01 |
| CA2498047C (en) | 2009-05-19 |
| JP2006502237A (ja) | 2006-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2005003264A0 (en) | Novel imidazole compounds as transforming growth factor (TGD) inhibitors. | |
| AP2005003260A0 (en) | Novel triazole compounds as transforming growth factor (TGF) inhibitors. | |
| AU2003301302A1 (en) | Pyradazine compounds as gsk-3 inhibitors | |
| AU2003292429A1 (en) | Pyrazole compounds | |
| HK1100219A1 (en) | Novel condensed imidazole derivatives | |
| AU2003257094A1 (en) | Substituted benzimidazole compounds | |
| AU2003271566A1 (en) | Pyrrolopyrazines as kinase inhibitors | |
| AU2002349754A1 (en) | Novel 1,2,4-triazole compound | |
| AU2003262244A1 (en) | Nitrogen-containing compounds | |
| AU2003266949A1 (en) | Compounds | |
| AU2003221098A1 (en) | Oligofluorenylene compounds | |
| AP2005003263A0 (en) | Pyrazole derivatives as transforming growth factor(TGF) inhibitors. | |
| HK1080845A1 (en) | (Imidazol-1-yl-methyl)-pyridazine as nmda receptorblocker | |
| AU2003279366A1 (en) | Novel compounds | |
| AU2003211385A1 (en) | Azole compounds | |
| AU2003231872A1 (en) | Imidazolium cxcr3 inhibitors | |
| AU2003212310A1 (en) | (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors | |
| AU2003281039A1 (en) | Imidazole derivative | |
| AU2003218170A1 (en) | Autoinducer compounds | |
| AU2003215635A1 (en) | Thiazol-2-yl-imine compounds as pde-7 inhibitors | |
| AU2003216859A1 (en) | Amidoacetonitrile compounds | |
| AU2003222206A1 (en) | Novel benzimidazole compounds | |
| AU2002951868A0 (en) | Compound i | |
| AU2003292667A1 (en) | Benzocycloheptapyridine compounds | |
| AU2003251259A1 (en) | Novel compounds |